Gisbert Weckbecker, Biel-Benken CH
Gisbert Weckbecker, Biel-Benken CH
Patent application number | Description | Published |
---|---|---|
20090069225 | SOMATOSTATIN ANALOGUES - The invention provides cyclo[{4-(NH | 03-12-2009 |
20090202541 | COMBINATION COMPRISING N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2-METHYLPHENYL)-4-(3-P- YRIDYL)-2PYRIMIDINE-AMINE AND A CHEMOTHERAPEUTIC AGENT - A method of treating a warm-blooded animal, especially a human, having a proliferative disease or acute or chronic transplant rejection comprising administering to the animal a combination which comprises (a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and (b) a chemotherapeutic agent selected from antineoplastic agents, especially as defined herein, and agents effective in treating acute or chronic transplant rejection; a combination comprising (a) and (b) as defined above and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease, especially a solid tumor disease. | 08-13-2009 |
20100152105 | USE OF RAPAMYCIN DERIVATIVES IN CHRONIC REJECTION - The present invention is directed to the use of a rapamycin derivative of formula I in combination with cyclosporin for preventing or treating manifestations of chronic rejection in a recipient of an organ or tissue transplant. | 06-17-2010 |
20110166320 | SOMATOSTATIN ANALOGUES - The invention provides cyclo[{4-(NH | 07-07-2011 |
20110172157 | SOMATOSTATIN ANALOGUES - The invention provides cyclo[{4-(NH | 07-14-2011 |
20120177690 | USE OF RAPAMYCIN DERIVATIVES IN VASCULOPATHIES AND XENOTRANSPLANTATION - Use of a rapamycin derivative of formula I as defined in the claims for preventing or treating vasculopathies and manifestations of xenotransplantation. | 07-12-2012 |
20140187574 | USE OF RAPAMYCIN DERIVATIVES IN VASCULOPATHIES AND XENOTRANSPLANTATION - Use of a rapamycin derivative of formula I as defined in the claims for preventing or treating vasculopathies and manifestations of xenotransplantation. | 07-03-2014 |
20150218223 | Somatostatin Analogues - The invention provides cyclo[{4-(NH | 08-06-2015 |